General
Preferred name
SOVAPREVIR
Synonyms
ACH 0141625 ()
ACH0141625 ()
ACH-0141625 ()
ACH1625 ()
ACH 1625 ()
ACH-1625 ()
P&D ID
PD058699
CAS
1001667-23-7
Tags
available
drug candidate
Drug indication
Hepatitis C virus infection
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
1173
DESCRIPTION
Sovaprevir is a non-structural 3 (NS3) protease inhibitor with antiviral activity for the treatment of HCV infection.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
4
ChEMBL Drugs
DrugBank
DrugMAP
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
799.36
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
2
Rotatable Bonds
13
Ring Count
7
Aromatic Ring Count
3
cLogP
4.99
TPSA
164.31
Fraction CSP3
0.51
Chiral centers
5.0
Largest ring
6.0
QED
0.23
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
HCV NS3 protease
Pathway
Microbiology/virology
Proteases/Proteasome
Source data
